Clinical severity of SARS-CoV-2 omicron variant compared with delta among hospitalized COVID-19 patients in Belgium during autumn and winter season 2021 …

…, M Vandromme, L De Mot, R Brondeel, V Stouten… - Viruses, 2022 - mdpi.com
This retrospective multi-center matched cohort study assessed the risk for severe COVID-19
(combination of severity indicators), intensive care unit (ICU) admission, and in-hospital …

Incidence and risk factors of COVID-19 vaccine breakthrough infections: a prospective cohort study in Belgium

V Stouten, P Hubin, F Haarhuis, JAF van Loenhout… - Viruses, 2022 - mdpi.com
The objective of this study was to investigate the incidence and risk factors associated with
COVID-19 vaccine breakthrough infections. We included all persons ≥18 years that had …

Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA

V Stouten, R Westhovens, S Pazmino… - …, 2019 - academic.oup.com
Objectives To investigate whether MTX should be combined with an additional DMARD and
bridging glucocorticoids as initial treatment for patients with early RA to induce an effective …

[HTML][HTML] Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021

…, K Proesmans, L Cornelissen, H Van Oyen, V Stouten… - Vaccine, 2022 - Elsevier
Background During the first half of 2021, we observed high vaccine effectiveness (VE)
against SARS-CoV2-infection. The replacement of the alpha-‘variant of concern’ (VOC) by the …

[HTML][HTML] Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022

…, K Proesmans, L Cornelissen, H Van Oyen, V Stouten… - Vaccine, 2023 - Elsevier
Objectives Vaccine effectiveness against transmission (VET) of SARS-CoV-2-infection can be
estimated from secondary attack rates observed during contact tracing. We estimated VET, …

The ideal mHealth-application for rheumatoid arthritis: qualitative findings from stakeholder focus groups

…, S Pazmino, D Bertrand, V Stouten… - BMC Musculoskeletal …, 2021 - Springer
Background Shifts in treatment strategies for rheumatoid arthritis (RA) have made ambulatory
care more labour-intensive. These developments have prompted innovative care models, …

Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the …

V Stouten, R Westhovens, S Pazmino… - Annals of the …, 2021 - ard.bmj.com
… 1.http://orcid.org/0000-0002-0162-2202Veerle Stouten1, … Stouten V , et al … Patrick
Verschueren and Veerle Stouten affirm that this manuscript is an honest, accurate, and transparent …

One in five patients with rapidly and persistently controlled early rheumatoid arthritis report poor well-being after 1 year of treatment

…, P Verschueren, D De Cock, A De Groef, V Stouten… - RMD open, 2020 - rmdopen.bmj.com
Objectives To identify and characterise a subgroup of patients with early rheumatoid arthritis
(RA) reporting not feeling well 1 year after treatment initiation despite achieving optimal …

Comorbidity burden in the first three years after diagnosis in patients with rheumatoid arthritis, psoriatic arthritis or spondyloarthritis: a general practice registry-based …

V Stouten, S Pazmino, P Verschueren, P Mamouris… - RMD open, 2021 - rmdopen.bmj.com
Objectives Rheumatoid arthritis (RA), psoriatic arthritis (PsA) and spondyloarthritis (SpA)
are chronic inflammatory rheumatic conditions with high levels of comorbidity requiring …

Patient‐reported outcome data from an early rheumatoid arthritis trial: opportunities for broadening the scope of treating to target

K Van der Elst, P Verschueren, V Stouten… - Arthritis care & …, 2019 - Wiley Online Library
Objective Treating early, intensively, and to target leads to rapid disease control, preventing
joint damage and loss of function in early rheumatoid arthritis ( RA ). We report the effect of …